IBRNvsSMIG
iShares Neuroscience and Healthcare ETF against AAM BAHL & GAYNOR SMALL/MID CAP INCOME GROWTH ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | SMIG | |
|---|---|---|
| Expense ratio | 0.47% | — |
| Assets | $6640.17T | $554M |
| Net flow, 1 month | +$94K | — |
| Net flow, 1 year | +$2M | — |
| Return, YTD | +0.7% | +8.7% |
| Return, 1 year | +18.6% | +6.1% |
| Avg daily volume | 2K | 243K |
| Holdings | 54 | 56 |
| Listed | Aug 24, 2022 | Jan 22, 2024 |
| Options market | Yes | No |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS